All In Biotech

Free tool

FAERS Monitor: Ecoza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205175 or its brand name (Ecoza, Econazole Nitrate). Reports on generic versions are filed under their own applications.

Reports

947

Serious

615

65% of reports

Hospitalization

335

Death reported

57

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue63
  • drug ineffective59
  • rash50
  • dyspnoea48
  • nausea48
  • pain47
  • diarrhoea45
  • dizziness41
  • asthenia39
  • headache39
  • pruritus39
  • renal failure38
  • anxiety36
  • drug interaction34
  • fall34

Reports by year received

View as table
YearReports
20048
20059
200613
200719
200821
200928
201018
201134
201233
201335
201415
201562
201664
201774
201879
201964
202073
202148
202240
202353
202449
202557
202651

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,212 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
renal failureSignal386.44.7167
drug interactionSignal344.83.498
anxietySignal362.82.041
rashSignal502.51.946
astheniaSignal392.31.728
fallSignal342.31.623
pruritusSignal392.31.726
dyspnoea481.91.420
dizziness411.81.415
fatigue631.81.422
pain471.71.313
diarrhoea451.51.28
headache391.41.04
nausea481.31.04
drug ineffective591.00.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.